A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira vaccine in Healthy 'Adults' aged greater than or equal to 18 to < 60 years and in Healthy 'Older Adults' aged greater than or equal to 60 years for the 2008/2009 Northern Hemisphere Influenza Season.

Trial Profile

A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira vaccine in Healthy 'Adults' aged greater than or equal to 18 to < 60 years and in Healthy 'Older Adults' aged greater than or equal to 60 years for the 2008/2009 Northern Hemisphere Influenza Season.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top